Navigation Links
Codexis Opens Singapore Laboratory

SINGAPORE, Oct. 24 /PRNewswire/ -- Codexis, Inc., a private biotechnology company and leading developer of clean manufacturing processes, today announced the opening of Codexis Laboratories Singapore Pte. Ltd. (CLS). CLS is the company's first research facility in Asia, and is an expansion of the company's research and development operations in the U.S. and Europe. CLS will support the company's pharmaceuticals business in both the innovator and generics markets.

The Guest of Honor at the laboratory opening ceremony was Mr. S. Iswaran, Minister of State for Trade and Industry. Other guests included Chu Swee Yeok, Bio*One Chief Executive Officer, Alan Shaw, Ph.D., Codexis President and Chief Executive Officer, Thomas Baruch, Chairman of the Board and other members of the company's Board of Directors. Bio*One Capital led the Codexis Series D private financing round in August 2006.

"Our expansion to Singapore is a significant part of our global development strategy," Dr. Shaw said. "Singapore offers us access to a highly skilled workforce, proximity to our growing customer base in Asia, and a productive business environment as our company grows. Codexis Laboratories Singapore will play an important role in the development of new products serving our pharmaceuticals markets worldwide."

"We are pleased that Codexis, one of the top biocatalyst companies in the world, has chosen to set up its research facility in Singapore," said Mr. S. Iswaran. "This investment is indeed a strong endorsement for our ability to host such cutting-edge R&D activities, and will, no doubt, contribute to ensuring the long-term sustainability of our pharmaceuticals manufacturing sector."

"Bio*One is delighted to welcome Codexis to Singapore," said Ms. Swee-Yeok Chu. "Our investment in Codexis reflects Bio*One's strong support for innovative biomedical sciences companies with cutting-edge technology that will significantly impact the growth of the biomedical industry in Singapore. We are pleased to be able to play a role in Codexis' expansion plans in Asia to further the company's growth."

The 20,000-square foot research and development center is in the Galen, in the Science Park III area of Singapore. When fully staffed, it is expected to house up to 70 R&D and operations personnel.

Codexis, Inc., a clean technology company, is a leading developer of biocatalytic process technologies that can substantially reduce the cost of manufacturing across a broad range of industries. These technologies enable novel solutions for efficient, cost-effective and environmentally-friendly processes for pharmaceutical, energy and industrial chemical applications. In 2006, the U.S. EPA recognized Codexis with a Presidential Green Chemistry Challenge Award. Codexis is a registered trademark of Codexis, Inc. For more information, please visit

Contact: Singapore: Cecilia Tan or Alicia Thong, Foreword Communications

Pte Ltd, or, +65 6338-5918.

US: Justin Jackson,, Burns McClellan, work,

212-213-0006, cell, 917-535-3248 or Lyn Christenson,, 650-298-5368

SOURCE Codexis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. NanoRite Innovation Center opens with small science, big promise
2. TomoTherapy opens technical training center
3. Japanese telecom opens liason office at UW-Platteville
4. Test center for RFID capabilities opens next week
5. Eau Claire business-plan contest opens
6. GE Healthcare opens facility meant for 2,000 employees
7. Space Place opens new astronomy center
8. Research on fruit flies opens up possibilities for human treatments
9. Paper technology transfer center opens in Green Bay
10. Nanotech exhibit opens at UW-Madison
11. Doyles Japan trip opens doors and minds for Wisconsin
Post Your Comments:
(Date:11/24/2015)... 24, 2015  Twist Bioscience, a company focused ... Ph.D., Twist Bioscience chief executive officer, will present ... December 1, 2015 at 3:10 p.m. Eastern Time at The ... --> --> ... Bioscience is on Twitter. Sign up to follow ...
(Date:11/24/2015)... , Nov. 24, 2015 Capricor Therapeutics, ... focused on the discovery, development and commercialization of first-in-class ... Chief Executive Officer, is scheduled to present at the ... at 10:50 a.m. EST, at The Lotte New York ... . . --> ...
(Date:11/24/2015)... , Nov. 24, 2015 According to two new ... 2005. This is something that many doctors, scientists, and public ... questions remains: with fewer PSA tests being done, will there ... Dr. David Samadi, "Despite the efforts made ... remains the second leading cancer cause of death in men, ...
(Date:11/23/2015)... ... 23, 2015 , ... Noblis, Inc., a leading provider of science, technology, and ... Geospatial Intelligence Agency (NGA), has joined the Noblis NSP team as President of the ... intelligence community and the private sector,” said L. Roger Mason, Jr., Ph.D. , ...
Breaking Biology Technology:
(Date:11/18/2015)... -- As new scientific discoveries deepen our understanding of how ... face challenges in better using that knowledge to guide ... more children continue to survive pediatric cancer, that counseling ... John M. Maris, M.D ., a pediatric ... . --> John M. Maris, M.D ...
(Date:11/17/2015)... Calif. , Nov. 17, 2015  Vigilant Solutions ... has joined its Board of Directors. ... Board after recently retiring from the partnership at TPG ... 107 companies with over $140 Billion in revenue.  He ... improvement across all the TPG companies, from 1997 to ...
(Date:11/12/2015)... 12, 2015  Arxspan has entered into an ... Harvard for use of its ArxLab cloud-based suite ... The partnership will support the institute,s efforts to ... research information internally and with external collaborators. The ... managing the Institute,s electronic laboratory notebook, compound and ...
Breaking Biology News(10 mins):